Tag Archives: PASC

Research review: Immunoglobulin therapy for ME/CFS

Back to the Future? Immunoglobulin therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, by  Helen Brownlie and Nigel Speight in Healthcare 2021, 9(11), 1546; [doi.org/10.3390/healthcare9111546]   12 Nov 2021 (This article belongs to the Special Issue ME/CFS – the Severely and Very Severely Affected)   … Continue reading

Posted in News | Tagged , , , , , , , , | Comments Off on Research review: Immunoglobulin therapy for ME/CFS

Research review: Redox imbalance links COVID-19 & ME/CFS

Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome, by Bindu D Paul, Marian D Lemle, Anthony L Komaroff, Solomon H Snyder in PNAS August 24,  2021 118 (34); [doi.org/10.1073/pnas.2024358118]   Review abstract: Although most patients recover from acute COVID-19, … Continue reading

Posted in News | Tagged , , , , , , , , , , , , | Comments Off on Research review: Redox imbalance links COVID-19 & ME/CFS

Insights from ME/CFS may help unravel the pathogenesis of post-acute COVID-19 syndrome

Insights from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome may help unravel the pathogenesis of post-acute COVID-19 syndrome, by Anthony L Komaroff, W Ian Lipkin in Trends in Molecular Medicine, 7 June 2021 [doi.org/10.1016/j.molmed.2021.06.002]   Highlights: In some people, the aftermath of acute … Continue reading

Posted in News | Tagged , , , , , | Comments Off on Insights from ME/CFS may help unravel the pathogenesis of post-acute COVID-19 syndrome